Waleed H. Hassanein
Net Worth
Last updated:
What is Waleed H. Hassanein net worth?
The estimated net worth of Dr. Waleed H. Hassanein is at least $58,515,532 as of 15 Oct 2024. He owns shares worth $7,520,446 as insider, has earned $45,356,706 from insider trading and has received compensation worth at least $5,638,380 in TransMedics Group, Inc..
What is the salary of Waleed H. Hassanein?
Dr. Waleed H. Hassanein salary is $939,730 per year as Founder, MD, Chief Executive Officer, Pres & Director in TransMedics Group, Inc..
How old is Waleed H. Hassanein?
Dr. Waleed H. Hassanein is 57 years old, born in 1968.
What stocks does Waleed H. Hassanein currently own?
As insider, Dr. Waleed H. Hassanein owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
TransMedics Group, Inc. (TMDX) | Founder, MD, Chief Executive Officer, Pres & Director | 61,643 | $122 | $7,520,446 |
What does TransMedics Group, Inc. do?
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Waleed H. Hassanein insider trading
TransMedics Group, Inc.
Dr. Waleed H. Hassanein has made 83 insider trades between 2019-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 193,074 units of TMDX stock on 10 Mar 2023. As of 15 Oct 2024 he still owns at least 61,643 units of TMDX stock.
TransMedics Group key executives
TransMedics Group, Inc. executives and other stock owners filed with the SEC:
- Dr. Tamer I. Khayal (56) Chief Commercial Officer
- Dr. Waleed H. Hassanein (57) Founder, MD, Chief Executive Officer, Pres & Director
- Mr. Stephen Gordon (57) Chief Financial Officer. Treasurer & Sec.